col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


70 Ergebisse       Seite 1

 [1] 
Elsevier: Schizophrenia Research
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―04 COVID-19 outbreak in a ward led three patients to discontinue clozapine due to neutropenia: Call for urgent considerations regarding clozapine regulation in Japan Yuki Kikuchi, Sota Ueno, Bunichiro Onodera, Hiroaki Tanifuji, Hiroshi Komatsu, Hiroaki Tomita
2 [GO] 2025―Jan―08 Justice delayed? Wait times and behavioral emergencies in involuntary psychiatric treatment before and after COVID-19: A 3-year retrospective study Reuben Heyman-Kantor, Minnie Horvath Laury, Esther Schoenfeld, Cara Angelotta, Ann Kan, Kwang-Youn A. Kim, Richard G. Cockerill
3 [GO] 2024―Sep―14 Recognition of schizophrenia and quality of treatment during the COVID-19 pandemic: A Danish nationwide study Simon Ploug Gartner, Tina Bech Olesen, Henry Jensen, Lotte Maxild Mortensen, Lone Baandrup
4 [GO] 2024―Aug―28 What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services? Sorcha J. Cotter, Catherine L. Smith, Caroline X. Gao, Rahul Khanna, Brian O'Donoghue, Ellie Brown, Andrew Thompson
5 [GO] 2024―Aug―27 The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba - A population-based study Mina Shirinbakhshmasoleh, Laila Aboulatta, Christine Leong, Hayley Riel, Kun Liu, Joseph C. Delaney, et al. (+5)
6 [GO] 2024―Aug―01 Evaluating the impact of COVID-19 on medication adherence and health care utilization among individuals with psychotic disorders who are prescribed long-acting injectables (LAIs) or clozapine: A population-based study in Manitoba, Canada Yushi W. MacMillan-Wang, Jennifer M. Hensel, Christine Leong, Rajat Jayas, Eunice Valencia, Arianna Yorski, Kun Liu
7 [GO] 2024―Jul―20 Increased COVID-19 mortality in patients with schizophrenia: A retrospective study in Brazil Diogo Fernando Bornancin Costa, Paula Rossignoli, Deise Regina Sprada Pontarolli, Paulo Collodel Junior, Camilla Luz Assolari, Acácia Maria Lourenço Francisco Nasr, et al. (+3)
8 [GO] 2024―Jul―13 Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services Maria Thibault, Ahmed Jérôme Romain, Charles Tessier, Jean Manneville Jr. Theagene, Valérie Chauvin, Amal Abdel-Baki
9 [GO] 2024―Apr―10 COVID-19 pandemic and emergency department visits for psychosis: Visit volume, restraint use, medication use, psychiatric hospitalization, and length of stay Brittany M. Gouse, Rachel Oblath, Jada S. Gibbs, Ellen G. Reagan, Hannah E. Brown
10 [GO] 2024―Mrz―25 Association between discrimination and subsequent psychotic experiences in patients with COVID-19: A cohort study Zui Narita, Megumi Hazumi, Mayumi Kataoka, Kentaro Usuda, Daisuke Nishi
11 [GO] 2024―Feb―19 Tardive dyskinesia's under-recognition in the era of COVID-19 Derek Zhang, Samuel Law, Saadia Sediqzadah
12 [GO] 2023―Nov―14 Longitudinal observations of the severity of COVID-19 infection and its impact on clozapine/norclozapine levels and clozapine toxicity in patients experiencing multiple episodes Kimberly Clinebell, Jane Thomas, Melanie Yabs, K.N. Roy Chengappa
13 [GO] 2023―Sep―15 Letter to the editor: Clozapine plasma levels under co-medication with fluvoxamine during COVID-19 infection: A case report Maxim Kuzin, Carla Boeglin, Georgios Schoretsanitis, Manjinder Pannu, Wolfram Kawohl, Franziskos Xepapadakos
14 [GO] 2023―Sep―08 COVID-19 vaccination among patients with schizophrenia prescribed clozapine Yachana Panchal, Jessica M. Gannon, Janina-Marie Tatar, G.K. Balasubramani
15 [GO] 2023―Aug―23 Psychotic experiences, perceived stress, and suicidal ideation among the general population during the COVID-19 pandemic: Findings from Japan Andrew Stickley, Aya Shirama, Tomiki Sumiyoshi
16 [GO] 2023―Jul―14 Increasing disparities in cancer screening among people with severe mental illness during the COVID-19 pandemic Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Naoki Nakaya, Shiro Hinotsu, Maiko Fujimori, et al. (+2)
17 [GO] 2023―Mrz―28 Potential mechanisms between psychotic-like experiences and suicidal ideation in the context of COVID-19: A longitudinal study Yue Li, Liang Zhou, Dongfang Wang, Ling Jing, Meng Sun
18 [GO] 2023―Mrz―09 Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine Wen-Huei Siao, Fang-Yu Chang, Yi-Chyan Chen
19 [GO] 2023―Feb―10 Schizophrenia and COVID-19: A bibliometric analysis of trends and themes Suraj Kushe Shekhar
20 [GO] 2023―Jan―23 Psychotic-like experiences during COVID-19 lockdown among adolescents: Prevalence, risk and protective factors Dongfang Wang, Liang Zhou, Chunping Chen, Meng Sun
21 [GO] 2023―Jan―20 Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study Manuel Canal-Rivero, Javier Vázquez-Hernández, Marta León-Gómez, Silvia Maraver-Ayala, Luis Fernández-Portes, Soraya Sánhez-Benítez, et al. (+3)
22 [GO] 2023―Jan―03 Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders Leticia González-Blanco, Pilar A. Sáiz, Francesco Dal Santo, Leticia García-Álvarez, Luis Jiménez-Treviño, Gonzalo Paniagua, et al. (+3)
23 [GO] 2022―Okt―12 A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample Michael Joseph Minzenberg, Jong H. Yoon
24 [GO] 2022―Jun―27 Worsening of psychotic experiences in college students during the COVID-19 pandemic J. Zimmerman, N.R. DeTore, W. Deng, A. Burke, M. Nyer, D.J. Holt
25 [GO] 2022―Jun―06 A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts Shayna H. Schor, Jada S. Gibbs, Brittany M. Gouse, Hannah E. Brown
26 [GO] 2022―Mai―19 COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report K.N. Roy Chengappa, Jane Thomas, Charles E. Kahn, Kimberly Clinebell, Kelly K. Mullen, Lori Arbutiski, Emil Ivanov
27 [GO] 2022―Mrz―04 COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey Carlos Gustavo Costardi, Fernando Malinowski, Lais Fonseca, Luciene Redondo, Cristiano Noto, Ary Gadelha
28 [GO] 2022―Feb―26 Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing Michael D. Masucci, Victoria Martin, Thanh P. Le, Alex S. Cohen
29 [GO] 2022―Feb―17 Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia Luyu Zhang, Gregory P. Strauss
30 [GO] 2022―Feb―01 Pandemic paranoia, general paranoia, and their relationships with worry and beliefs about self/others - A multi-site latent class analysis Suzanne Ho-wai So, Chen Zhu, Tania M. Lincoln, Brandon A. Gaudiano, Jessica L. Kingston, Lyn Ellett, Eric M.J. Morris
31 [GO] 2022―Jan―24 Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Cintia R. Prokopez, Romina Farinola, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, et al. (+4)
32 [GO] 2022―Jan―24 First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report Sandeep Grover, Seema Rani, Komal Kohat, Sanjana Kathiravan, Garima Patel, Swapnajeet Sahoo, et al. (+3)
33 [GO] 2022―Jan―10 Clozapine toxicity and coronavirus disease 2019: A case report Maria Sagué-Vilavella, Hugo López-Pelayo, Néstor Arbelo, Mercè Cámara, Susana Gomes, Santiago Madero, et al. (+2)
34 [GO] 2022―Jan―05 Correlates of Psychotic Like Experiences (PLEs) During Pandemic: An Online Study Investigating a Possible Link Between the SARS-CoV-2 Infection and PLEs Among Adolescents Helin Yilmaz Kafali, Serkan Turan, Serap Akpınar, Müge Mutlu, Aslınur Özkaya Parlakay, Esra Çöp, Timothea Toulopoulou
35 [GO] 2021―Dez―22 An overall protective effect of antipsychotic drugs against COVID-19 seems implausible Ángel Ruiz de Pellón-Santamaría, Cristina Sarasqueta-Eizaguirre, Francisco Javier Basterrechea-Peña
36 [GO] 2021―Sep―16 Psychotic behaviors during COVID-19: Should conspiracist ideation be included within the continuum model of psychosis? Álex Escolà-Gascón, Abigail C. Wright
37 [GO] 2021―Sep―14 COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020 Hans Oh, Jessica Goehring, Ravi Rajkumar, Megan Besecker, Sasha Zhou, Jordan E. DeVylder
38 [GO] 2021―Sep―01 H1N109 pandemic research in people with schizophrenia providing insights into COVID-19 clinical care Paul A. Maguire, Rebecca E. Reay, Jeffrey C.L. Looi
39 [GO] 2021―Sep―01 Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample Joachim Kowalski, Łukasz Gawęda
40 [GO] 2021―Sep―01 Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China Zhipeng Wu, Zhening Liu, Zhulin Zou, Feiwen Wang, Mengran Zhu, Wen Zhang, et al. (+3)
41 [GO] 2021―Aug―07 Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India Sandeep Grover, Sanjana Kathiravan, Aarzoo Suman, Chandrima Naskar, Aseem Mehra, Swapnajeet Sahoo, Subho Chakrabarti
42 [GO] 2021―Jul―30 Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis Kelsey I. Macdonald, Michael J. Spilka, Lisa A. Bartolomeo, Ian M. Raugh, Alysia M. Berglund, Gregory P. Strauss
43 [GO] 2021―Jul―30 Can antipsychotic use protect from COVID-19? Luiz Dratcu, Xavier Boland
44 [GO] 2021―Jul―22 Starting clozapine in patients with schizophrenia during the ongoing pandemic Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabarti
45 [GO] 2021―Jul―14 The immediate impact of the COVID-19 pandemic on attenuated positive symptoms and functioning in individuals at clinical high risk for psychosis: A pilot study Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Barbara A. Cornblatt
46 [GO] 2021―Jul―08 The role of antipsychotics against COVID-19: A topic for debate M. Canal-Rivero, R. Catalán-Barragán, A. Rubio-García, N. Garrido-Torres, B. Crespo-Facorro, M. Ruiz-Veguilla, et al. (+4)
47 [GO] 2021―Jul―02 Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions Brian O'Donoghue, Emily Castagnini, Alison Langstone, Nathan Mifsud, Andrew Thompson, Eoin Killackey, Patrick McGorry
48 [GO] 2021―Jun―26 Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population” Ahmad Amjed Toubasi
49 [GO] 2021―Jun―23 An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses Cintia R. Prokopez, Miguel Vallejos, Lorena S. Lopredo, Luciano E. Sfriso, Luciana C. Chiapella, Claudio Arce, et al. (+4)
50 [GO] 2021―Jun―16 New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus Umit Haluk Yesilkaya, Meltem Sen, Nesrin Karamustafalioglu
51 [GO] 2021―Mrz―14 Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19 Meng Sun, Dongfang Wang, Ling Jing, Liang Zhou
52 [GO] 2021―Feb―21 Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population M. Canal-Rivero, R. Catalán Barragán, A. Rubio García, N. Garrido Torres, B. Crespo-Facorro, M. Ruiz-Veguilla
53 [GO] 2021―Feb―21 Induced ideas of reference during social unrest and pandemic in Hong Kong Stephanie M.Y. Wong, Christy L.M. Hui, Corine S.M. Wong, Y.N. Suen, Sherry K.W. Chan, Edwin H.M. Lee, et al. (+3)
54 [GO] 2021―Jan―18 Factors associated with mask wearing among psychiatric inpatients during the COVID-19 pandemic Ha-Ran Jung, Cheol Park, Mina Kim, Min Jhon, Ju-Wan Kim, Seunghyong Ryu, et al. (+6)
55 [GO] 2020―Aug―06 The COVID pandemic and the endemic disparities in care across race for psychotic disorders Fabio Ferrarelli, Matcheri S. Keshavan
56 [GO] 2020―Jul―25 COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? Leticia González-Blanco, Francesco Dal Santo, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Carlota Moya Lacasa, Gonzalo Paniagua, et al. (+3)
57 [GO] 2020―Jul―25 Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? B. Nobile, M. Durand, P. Courtet, P. Van de Perre, N. Nagot, J.P. Molès, E. Olié
58 [GO] 2020―Jun―15 The DOSMD challenge and the COVID-19 conundrum Ravi Philip Rajkumar
59 [GO] 2020―Jun―15 Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic Jagadisha Thirthalli, Narayana Manjunatha, Suresh Bada Math
60 [GO] 2020―Mai―28 Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic Sandeep Grover, Eepsita Mishra, Subho Chakrabarti, Aseem Mehra, Swapnajeet Sahoo
61 [GO] 2020―Mai―27 The impact of COVID-19 on individuals living with serious mental illness Kareem Hamada, Xiaoduo Fan
62 [GO] 2020―Mai―26 Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic Jessica Nichols, Jessica M. Gannon, Judith Conlogue, Deepak Sarpal, Jamie L. Montgomery, Robin Sherwood, et al. (+4)
63 [GO] 2020―Mai―16 The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19 Urvakhsh Meherwan Mehta, Ganesan Venkatasubramanian, Prabha S. Chandra
64 [GO] 2020―Mai―14 Clozapine treated patients and COVID-19: Ensuring continued care through collaboration Jonathan G. Leung, Terri S. Wittenberger, Kathryn M. Schak
65 [GO] 2020―Mai―13 Psychotic experiences in student population during the COVID-19 pandemic Michal Hajdúk, Daniel Dančík, Jakub Januška, Viktor Svetský, Alexandra Straková, Michal Turček, et al. (+4)
66 [GO] 2020―Mai―07 Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions Jessica M. Gannon, Judith Conlogue, Robin Sherwood, Jessica Nichols, Juliette R. Ballough, Noreen M. Fredrick, K.N. Roy Chengappa
67 [GO] 2020―Mai―06 The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research Ellie Brown, Richard Gray, Samantha Lo Monaco, Brian O'Donoghue, Barnaby Nelson, Andrew Thompson, et al. (+2)
68 [GO] 2020―Apr―27 Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge Petru Ifteni, Lorena Dima, Andreea Teodorescu
69 [GO] 2020―Apr―16 COVID-19, mobile health and serious mental illness John Torous, Matcheri Keshavan
70 [GO] 2020―Apr―04 Is schizophrenia research relevant during the COVID-19 pandemic? Henry R. Cowan
 [1] 

70 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec